Viewing Study NCT01210768


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-01-01 @ 5:12 PM
Study NCT ID: NCT01210768
Status: UNKNOWN
Last Update Posted: 2021-11-23
First Post: 2010-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients
Sponsor: TTY Biopharm
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module